A Study of AL8326 in Non-Small Cell Lung Cancer
NCT06794957
·
clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
158
Enrollment
INDUSTRY
Sponsor class
Conditions
Non-small Cell Lung Cancer
Interventions
DRUG:
AL8326 tablets
Sponsor
Advenchen Laboratories, LLC